Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thailand's H1N1 Flu Vaccine Maker Offers Trial Guidelines

This article was originally published in PharmAsia News

Executive Summary

Thailand's Government Pharmaceutical Organization is issuing guidelines expected to limit clinical trials for its H1N1 flu vaccine to 430 volunteers between the age of 12 and 49 years old. The GPO plans to begin producing a nasal spray vaccine in August and to launch a four-month trial in September. The GPO drug represents Thailand's first attempt to make a vaccine from a live virus, developed under the aegis of the World Health Organization. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts